Stock listing
Munich:6HV1 Rezolute, Inc. Aktie
German listing (Munich) of Rezolute, Inc. · home listing NASDAQ:RZLT
Follow Rezolute, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:RZLT
$3.95 USD -0.17 (-4.1%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RZLT
- Day range
- $3.88 – $4.16 USDOct 30, 2026
- Volume
- 779,004 sharesOct 30, 2026
- Market cap
- $382.1M USDAt the close on Oct 30, 2026 · price × 96.72M shares outstanding
- 52-week range
- $1.07 – $11.46 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $6.51M USDMedian day 1.35M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RZLT · Home | $3.95 USD | -0.17 (-4.1%) | 779,004 | $4.05 | $4.16 | $3.88 | $4.12 | Close on Oct 30, 2026 |
| Frankfurt:6HV1 | €3.52 EUR | +0.12 (+3.5%) | — | €3.60 | €3.60 | €3.52 | €3.40 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:RZLT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.95 | -0.17 | -4.1% | $4.05 | $4.16 | $3.88 | 779,004 | |
| $4.12 | -0.10 | -2.4% | $4.20 | $4.33 | $4.075 | 756,226 | |
| $4.22 | +0.11 | +2.7% | $4.11 | $4.235 | $4.02 | 1,414,466 | |
| $4.11 | +0.29 | +7.6% | $3.80 | $4.14 | $3.779 | 1,400,113 | |
| $3.82 | -0.035 | -0.9% | $3.87 | $3.89 | $3.735 | 1,543,500 | |
| $3.855 | -0.005 | -0.1% | $3.78 | $3.938 | $3.70 | 1,198,100 | |
| $3.86 | +0.16 | +4.3% | $3.67 | $3.965 | $3.67 | 1,355,600 | |
| $3.70 | 0.00 | 0.0% | $3.70 | $3.785 | $3.645 | 930,000 | |
| $3.70 | 0.00 | 0.0% | $3.66 | $3.84 | $3.63 | 1,225,900 | |
| $3.70 | +0.12 | +3.4% | $3.62 | $3.72 | $3.37 | 1,778,900 | |
| $3.58 | -0.32 | -8.2% | $3.90 | $3.99 | $3.56 | 1,397,900 | |
| $3.90 | -0.33 | -7.8% | $4.25 | $4.33 | $3.90 | 2,118,600 | |
| $4.23 | -0.38 | -8.2% | $4.52 | $4.70 | $4.21 | 1,693,700 | |
| $4.61 | -0.26 | -5.3% | $4.825 | $4.85 | $4.56 | 1,507,700 | |
| $4.87 | 0.00 | 0.0% | $4.86 | $4.91 | $4.72 | 1,009,600 | |
| $4.87 | +0.23 | +5.0% | $4.60 | $4.91 | $4.55 | 1,872,900 | |
| $4.64 | +0.26 | +5.9% | $4.33 | $4.685 | $4.32 | 2,197,700 | |
| $4.38 | +0.06 | +1.4% | $4.29 | $4.56 | $4.23 | 1,689,800 | |
| $4.32 | -0.01 | -0.2% | $4.64 | $4.64 | $4.15 | 2,191,800 | |
| $4.33 | +0.32 | +8.0% | $4.05 | $4.535 | $3.82 | 4,197,500 | |
| $4.01 | -0.06 | -1.5% | $4.13 | $4.20 | $3.965 | 1,646,300 | |
| $4.07 | -0.07 | -1.7% | $4.14 | $4.175 | $4.04 | 981,200 | |
| $4.14 | +0.05 | +1.2% | $4.19 | $4.345 | $4.135 | 1,702,800 | |
| $4.09 | -0.09 | -2.2% | $4.545 | $4.57 | $4.07 | 1,517,800 | |
| $4.18 | +0.28 | +7.2% | $3.85 | $4.195 | $3.76 | 1,587,600 | |
| $3.90 | -0.04 | -1.0% | $3.99 | $4.05 | $3.871 | 2,046,700 | |
| $3.94 | -0.06 | -1.5% | $4.03 | $4.085 | $3.835 | 3,868,200 | |
| $4.00 | -0.04 | -1.0% | $4.05 | $4.13 | $3.98 | 1,683,200 | |
| $4.04 | +0.13 | +3.3% | $3.96 | $4.09 | $3.95 | 928,500 | |
| $3.91 | +0.07 | +1.8% | $3.84 | $3.93 | $3.73 | 1,082,700 | |
| $3.84 | -0.11 | -2.8% | $3.95 | $3.95 | $3.665 | 2,527,200 | |
| $3.95 | -0.03 | -0.8% | $4.09 | $4.14 | $3.885 | 1,832,100 | |
| $3.98 | -0.17 | -4.1% | $4.20 | $4.23 | $3.875 | 2,044,200 | |
| $4.15 | -0.10 | -2.4% | $4.28 | $4.28 | $4.11 | 753,000 | |
| $4.25 | +0.03 | +0.7% | $4.18 | $4.28 | $4.09 | 828,000 | |
| $4.22 | +0.05 | +1.2% | $4.23 | $4.355 | $4.08 | 1,352,700 | |
| $4.17 | +0.11 | +2.7% | $4.03 | $4.35 | $3.97 | 2,224,300 | |
| $4.06 | -0.34 | -7.7% | $4.55 | $4.55 | $4.02 | 2,071,900 | |
| $4.40 | -0.18 | -3.9% | $4.51 | $4.53 | $4.37 | 866,100 | |
| $4.58 | +0.04 | +0.9% | $4.49 | $4.62 | $4.44 | 716,900 | |
| $4.54 | -0.02 | -0.4% | $4.59 | $4.615 | $4.47 | 771,900 | |
| $4.56 | +0.06 | +1.3% | $4.50 | $4.61 | $4.43 | 857,300 | |
| $4.50 | -0.19 | -4.1% | $4.64 | $4.71 | $4.43 | 1,020,400 | |
| $4.69 | +0.07 | +1.5% | $4.65 | $4.74 | $4.60 | 749,100 | |
| $4.62 | -0.36 | -7.2% | $4.95 | $4.95 | $4.58 | 1,084,900 | |
| $4.98 | -0.06 | -1.2% | $5.07 | $5.081 | $4.935 | 784,200 | |
| $5.04 | +0.03 | +0.6% | $5.01 | $5.10 | $4.875 | 1,368,000 | |
| $5.01 | 0.00 | 0.0% | $4.94 | $5.22 | $4.94 | 1,798,771 | |
| $5.01 | -0.08 | -1.6% | $5.03 | $5.13 | $4.70 | 1,297,415 | |
| $5.09 | +0.43 | +9.2% | $4.68 | $5.635 | $4.646 | 6,500,000 | |
| $4.66 | -0.06 | -1.3% | $4.68 | $4.71 | $4.60 | 971,400 | |
| $4.72 | +0.06 | +1.3% | $4.77 | $4.87 | $4.65 | 1,220,200 | |
| $4.66 | -0.02 | -0.4% | $4.62 | $4.72 | $4.58 | 912,800 | |
| $4.68 | +0.08 | +1.7% | $4.58 | $4.695 | $4.56 | 535,200 | |
| $4.60 | 0.00 | 0.0% | $4.59 | $4.75 | $4.44 | 657,100 | |
| $4.60 | -0.10 | -2.1% | $4.74 | $4.885 | $4.58 | 800,500 | |
| $4.70 | +0.08 | +1.7% | $4.65 | $4.805 | $4.62 | 2,390,900 | |
| $4.62 | -0.06 | -1.3% | $4.68 | $4.725 | $4.61 | 642,000 | |
| $4.68 | -0.01 | -0.2% | $4.68 | $4.76 | $4.595 | 756,400 | |
| $4.69 | -0.01 | -0.2% | $4.76 | $4.84 | $4.545 | 986,300 | |
| $4.70 | +0.02 | +0.4% | $4.715 | $4.925 | $4.65 | 924,900 | |
| $4.68 | -0.29 | -5.8% | $5.03 | $5.04 | $4.66 | 1,374,300 | |
| $4.97 | +0.06 | +1.2% | $4.96 | $5.25 | $4.955 | 2,541,400 | |
| $4.91 | +0.19 | +4.0% | $4.542 | $4.945 | $4.51 | 1,428,200 | |
| $4.72 | -0.16 | -3.3% | $4.91 | $4.91 | $4.545 | 777,000 | |
| $4.88 | +0.18 | +3.8% | $4.72 | $4.935 | $4.66 | 805,800 |
- Ticker
- Munich:6HV1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Oct 14, 2026
Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 34 slides
Latest news
Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Oct 14, 2026
Closed $3.90 (-7.8%) on Oct 15, 2026
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
Oct 5, 2026
Closed $4.33 (+8.0%) on Oct 5, 2026
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
Sep 24, 2026
Closed $3.90 (-1.0%) on Sep 25, 2026
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
Sep 9, 2026
Closed $4.06 (-7.7%) on Sep 9, 2026
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
Jun 17, 2026
Closed $4.79 (+4.8%) on Jun 17, 2026
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
Jun 4, 2026
Closed $4.51 (-1.5%) on Jun 4, 2026
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Jun 2, 2026
Closed $4.00 (+10.8%) on Jun 2, 2026
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
May 12, 2026
Closed $3.33 (+0.9%) on May 13, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 34 slides · October 2026
Investor Presentation (August 2026)
Investor deck · 31 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 38 slides · May 2026
Investor Presentation (February 2026)
Investor deck · 34 slides · February 2026
Rezolute, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 120 in all · newest Oct 14, 2026 · oldest 2019
- Decks
- 22 decks · latest October 2026
Where Rezolute, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RZLT · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2QEWP | LS Exchange | Germany | EUR |
| BOATS:RZLT | BOATS | United States | USD |
| Lang & Schwarz:A2QEWP | Lang & Schwarz | Germany | EUR |
| Dusseldorf:6HV1 | Dusseldorf | Germany | EUR |
| Frankfurt:6HV1 | Frankfurt | Germany | EUR |
| Munich:6HV1 · This page | Munich | Germany | EUR |
| Stuttgart:6HV1 | Stuttgart | Germany | EUR |
| Tradegate:6HV1 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Rezolute, Inc.